What is the significance of a low ejection fraction (EF) in a 22-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A 22-year-old male with a low ejection fraction should seek immediate medical attention, as early intervention is crucial for preventing heart failure progression and improving quality of life. A normal ejection fraction for a young adult should be between 50-70%, representing the percentage of blood that leaves the left ventricle when it contracts 1. If a young male has an ejection fraction below 50%, this could indicate heart dysfunction and requires medical evaluation. Common causes of reduced ejection fraction in young adults include viral myocarditis, congenital heart defects, cardiomyopathy, or drug/alcohol toxicity. Symptoms of low ejection fraction may include fatigue, shortness of breath, swelling in legs, or reduced exercise tolerance.

Key Considerations

  • Treatment depends on the underlying cause but might include medications like ACE inhibitors, beta-blockers, or ARBs, as evidenced by the 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy 1.
  • Regular follow-up echocardiograms would be necessary to monitor heart function over time.
  • Lifestyle modifications including limited salt intake, regular moderate exercise as tolerated, and avoiding alcohol and tobacco can help support heart health regardless of the cause.
  • In patients with a low ejection fraction, achieving adequate BP control and promoting LVH regression is a central management goal, and any combination of antihypertensive drug classes should be considered as needed to achieve this goal 1.

Management Approach

  • Pharmacotherapy for heart failure with reduced ejection fraction should focus on the sequential addition and titration of medications demonstrated to reduce the risk of death and hospitalization in randomized controlled trials 1.
  • Consideration should be given to the global management of risk, including metabolic factors and obesity, in addition to aggressive antihypertensive therapy.
  • In patients with persistently-severe LV systolic dysfunction (EF <35%) despite adequate medical management, including BP control, ICD implantation should be considered.

From the Research

Significance of Low Ejection Fraction

A low ejection fraction (EF) in a 22-year-old male is a significant indicator of potential heart problems. The ejection fraction measures the percentage of blood that is pumped out of the left ventricle with each heartbeat. A low EF can indicate that the heart is not pumping efficiently, which can lead to various complications.

Implications of Low EF

  • A low EF can increase the risk of heart failure, arrhythmias, and other cardiovascular conditions 2.
  • Patients with severely reduced EF (≤15%) may require specialized management, including transvenous lead extraction, and may benefit from left ventricular assist devices to support heart function 3.
  • Beta-blocker treatment has been shown to improve EF in patients with heart failure, although the degree of improvement may vary depending on the specific beta-blocker and the underlying cause of heart failure 4.

Treatment Options

  • Combination therapy with ACE inhibitors or ARBs, beta-blockers, and mineralocorticoid receptor antagonists may be effective in reducing mortality in patients with heart failure and reduced EF 5.
  • Implantable cardiac defibrillators and cardiac resynchronization therapy with defibrillators may also be beneficial in reducing mortality in these patients 5.
  • In patients with aortic stenosis and low EF, surgical intervention with aortic valve replacement may be necessary to improve symptoms and outcomes 6.

Prognosis

  • A low EF is a strong predictor of long-term, all-cause mortality, with decreased EF associated with increased risk of death over a period of 10 years 2.
  • The severity of EF impairment is also associated with increased mortality, with more severe impairment corresponding to higher mortality rates 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.